Pattern recognition in menstrual bleeding diaries by statistical cluster analysis by Gerlinger, Christoph et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Women's Health
Open Access Research article
Pattern recognition in menstrual bleeding diaries by statistical 
cluster analysis
Christoph Gerlinger*1, Jens Wessel2,3, Gerd Kallischnigg4 and Jan Endrikat5,6
Address: 1Global Clinical Statistics, Bayer Schering Pharma AG, Müllerstraße 178, 13342 Berlin, Germany, 2Global Medical Affairs Women's 
Healthcare, Bayer Schering Pharma AG, Berlin, Germany, 3Klinik für Geburtsmedizin, Charité, Campus Virchow-Klinikum, Humboldt Universität, 
Berlin, Germany, 4Institute of Health Sciences, Berlin University of Technology, Berlin, Germany, 5Bayer Inc., Toronto, Ontario, Canada and 
6Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universität des Saarlands, Homburg (Saar), Germany
Email: Christoph Gerlinger* - christoph.gerlinger@bayerhealthcare.com; Jens Wessel - jens.wessel@bayerhealthcare.com; 
Gerd Kallischnigg - gerd.kallischnigg@tu-berlin.de; Jan Endrikat - jan.endrikat.b@bayer.com
* Corresponding author    
Abstract
Background: The aim of this paper is to empirically identify a treatment-independent statistical
method to describe clinically relevant bleeding patterns by using bleeding diaries of clinical studies
on various sex hormone containing drugs.
Methods: We used the four cluster analysis methods single, average and complete linkage as well
as the method of Ward for the pattern recognition in menstrual bleeding diaries.
The optimal number of clusters was determined using the semi-partial R2, the cubic cluster
criterion, the pseudo-F- and the pseudo-t2-statistic. Finally, the interpretability of the results from
a gynecological point of view was assessed.
Results: The method of Ward yielded distinct clusters of the bleeding diaries. The other methods
successively chained the observations into one cluster. The optimal number of distinctive bleeding
patterns was six. We found two desirable and four undesirable bleeding patterns. Cyclic and non
cyclic bleeding patterns were well separated.
Conclusion: Using this cluster analysis with the method of Ward medications and devices having
an impact on bleeding can be easily compared and categorized.
Background
Hormonal contraceptives and other treatments with
impact on the endometrium alter a woman's natural men-
strual bleeding pattern [1]. Any change in the bleeding
pattern has a major impact on the individual's quality of
life. An unsatisfactory bleeding pattern is one of the major
causes for stopping treatment with sex hormones, e.g. for
contraception, the treatment of menopausal symptoms,
or endometriosis.
An analysis of bleeding patterns is required by drug regu-
latory agencies such as the EMEA and the FDA in addition
to an analysis of efficacy and safety. Although the regula-
tory requirements for safety and efficacy of hormonal
preparations such as contraceptives or hormone replace-
ment therapies are well defined, e.g. [2], the EMEA's
guideline on contraceptives [3] requires only that the
bleeding pattern is studied in an active controlled study
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but does not specify how. The EMEA's guideline on hor-
mone replacement therapy [4] is not any more specific.
The aim of this paper is to empirically identify a treat-
ment-independent statistical method to describe clini-
cally relevant bleeding patterns by using bleeding diaries
of clinical studies on various sex hormone containing
drugs.
Methods
We analyzed bleeding dairies that were kept in clinical tri-
als involving various products used for hormonal fertility
control, hormone replacement therapy and endometrio-
sis. Mono-preparations as well as combined preparations
were included. Estrogens, e.g., estradiol, estradiolvalerate
or ethinylestradiol and a large variety of modern pro-
gestins, e.g, levonorgestrel, desogestrel, dienogest or dros-
pirenone, were the hormonal components of the drugs.
All trials were performed according to the principles of the
Declaration of Helsinki [5], the laws applicable in the
respective countries, and "Good Clinical Practices" (GCP)
[6]. All clinical studies have been approved by the compe-
tent ethics committees. The clinical trials were sponsored
by Bayer Schering Pharma AG or one of its subsidiaries.
The definitions of bleeding intensities that were recorded
daily in the bleeding diaries (see Figure 1) were slightly
different in the various studies. For the purpose of this
analysis, the bleeding intensity categories have been
standardized according to WHO terminology [7] as
"none", "spotting", and "bleeding". "Spotting" is defined
as any vaginal bleeding that does not require the use of
sanitary protection such as tampons or pads. "Bleeding" is
defined as vaginal bleeding that requires the use of sani-
tary protection. "None" is defined as neither "Spotting"
nor "Bleeding" on that day. These definitions are inde-
pendent of whether sanitary protection was actually used
or not. For the purpose of the cluster analyses, the bleed-
ing intensity scores 0 for "none", 1 for "spotting", and 2
for "bleeding" were used.
All cluster analysis algorithms implemented in SAS® Soft-
ware [8] require complete data. Therefore, we imputed
single missing entries in the bleeding diaries by the maxi-
mum of the bleeding intensities of the preceding and the
following day. We included all diaries that had a length of
at least 90 days in our analyses. This length was chosen to
comply with the definition of the reference period length
of the WHO [7]. In summary, the dataset consisted of one
record per woman with ninety score variables giving the
bleeding intensity score for each day.
The bleeding diary data was analyzed using different
agglomerative hierarchical cluster analyses because these
methods do not require previous knowledge as for exam-
ple a discriminant analysis. The bleeding patterns in the
diaries should be found by unsupervised pattern recogni-
Example of bleeding diary Figure 1
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tion [9]. As there is no single optimal cluster analysis pro-
cedure, we analyzed the data using the single linkage
method [10,11], the complete linkage method [12], the
average linkage method [13], and the method of Ward
[14].
As the number of different bleeding patterns was
unknown a priori, we used the semi-partial R2 [8], the
cubic cluster criterion [15], the pseudo-F- and the pseudo-
t2-statistic [8] to derive the optimal number of clusters.
Finally, we assessed whether the results of the cluster anal-
yses could be interpreted from a gynecological perspec-
tive.
Results
The clinical databases contained bleeding diaries of 5602
women. Of these 3246 (57.9%) women were treated with
hormone replacement therapy after menopause, 2035
(36.3%) were aged 18 to 35 and took an oral contracep-
tive, and 321 (5.7%) were treated for endometriosis. A
total of 4612 (82.3%) diaries were included in our analy-
ses because they covered at least 90 consecutive days. An
exploratory data analysis of the bleeding diaries revealed
that 1288 (27.9%) of the 4612 women in our dataset
never bled during the 90 days analyzed. On the other
hand, 3172 (68.8%) women had a unique bleeding pat-
tern that occurred only once in the dataset.
The cluster analyses using the single linkage, complete
linkage, and average linkage methods did not produce
clinically interpretable results. With all three methods the
effect of chaining occurred where the observations are suc-
cessively joined into a single large cluster (see Figure 2).
On the other hand, the method of Ward yielded a clear
separation of the bleeding diaries (see Figure 3) into dis-
tinct clusters. According to the semi-partial R2, the cubic
cluster criterion, the pseudo-F, and the pseudo-t statistic,
the solutions with three, four, six, and twelve clusters
could be of clinical relevance.
Comparing these solutions, we found out, that the solu-
tion with six clusters was the best to be interpreted clini-
cally. Three and four cluster did not distinguish the
different bleeding patterns to enough detail whereas
twelve clusters provided no more clinically useful insight
than six clusters. This solution is depicted in Figure 3 by
the solid horizontal line.
The cluster analysis revealed two clusters of cyclic bleed-
ing patterns containing 1235 and 386 diaries (see Figure
4) and four clusters of non-cyclic bleeding patterns con-
taining 1880, 590, 71, and 450 diaries (see Figure 5).
The cyclic bleeding patterns are clearly separated into a
desirable bleeding pattern (number 1 in Figure), which is
characterized by the regular monthly bleeding and a very
Dendrogramm of the single linkage method Figure 2
Dendrogramm of the single linkage method.
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Dendrogramm of the method of Ward Figure 3
Dendrogramm of the method of Ward. Note: The six clusters determined by the horizontal line are -from left to right- 
the clusters number 6, 5, 3, 4, 2, and 1.
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Cyclic bleeding patterns – mean bleeding intensity Figure 4
Cyclic bleeding patterns – mean bleeding intensity.BMC Women's Health 2009, 9:21 http://www.biomedcentral.com/1472-6874/9/21
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low frequency of intracyclic bleeding during hormone
intake, and an undesirable bleeding pattern (number 2 in
Figure 4), which is characterized by a less regular monthly
bleeding and a higher frequency of intracyclic bleeding,
starting always in the middle of the cycle.
Among the four non-cyclic bleeding patterns there are two
that are desirable bleeding patterns and two that are unde-
sirable. Bleeding pattern number 3 in Figure 5 shows
amenorrhea, a pattern typical of post menopausal women
taking continuously combined steroid hormone prepara-
tions. Bleeding pattern number 4 in Figure 5 can be inter-
preted as the pattern of fertile women which start
continuous steroid hormonal treatment, e.g. for the treat-
ment of endometriosis. The natural cyclic bleeding ceases
during the first month of treatment and thereafter reaches
amenorrhea as in pattern number 3. The bleeding patterns
5 and 6 in Figure 5 both show a high frequency of unde-
sirable spotting or bleeding. Pattern 6 is worse than pat-
tern 5.
Discussion
Several suggestions have been made in the literature over
the past years for the analysis of bleeding diaries [16-18],
all of them were based on theoretical considerations. To
our knowledge, this is the first analysis to recognise pat-
terns in bleeding diaries using empirical methods.
A hierarchical agglomerative cluster analysis with the
method of Ward yielded six bleeding patterns which allow
for a straightforward clinical interpretation, either desira-
ble or undesirable bleeding pattern for a certain treatment
target. In contrast the single, average and complete linkage
methods chained the data into a single cluster, which was
not interpretable from a gynaecologic point of view.
Conclusion
Using this cluster analysis with the method of Ward, treat-
ments (medications and devices) having an impact on
bleeding can be easily compared and categorized. This
analysis is independent of the treatment's route of admin-
istration (oral, transdermal, vaginal, intrauterine) and the
duration of treatment. Hormonal and non-hormonal
treatments can be easily compared. However, this method
is only useful in large clinical trials to characterize a new
product's bleeding pattern but it is not meaningful for the
physician treating an individual patient.
Since currently various innovative long-cycle contracep-
tive regimen are in development, this method might be
Continuous bleeding patterns – mean bleeding intensity Figure 5
Continuous bleeding patterns – mean bleeding intensity.
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useful to compare bleeding pattern from different studies
using one uniform method.
Competing interests
CG and JW are fulltime employees of Bayer Schering
Pharma AG, Berlin, Germany and JE is a fulltime
employee of Bayer Inc., Toronto, Ontario, Canada. Bayer
Schering Pharma AG funded this study and the article
processing charges.
GK declares that he has no competing interests.
Authors' contributions
JE, CG, and JW designed the study. CG performed the sta-
tistical analyses. CG and JE drafted the manuscript. GK
and JW critically reviewed the draft manuscript. All
authors read and approved the final manuscript.
References
1. Taubert HD, Kuhl H: Kontrazeption mit Hormonen, Ein Leitfaden für die
Praxis 2nd edition. Stuttgart Georg Thieme Verlag; 1995:153-161. 
2. Gerlinger C, Endrikat J, Meulen EA van der, Dieben TOM, Düsterberg
B: Recommendation for confidence interval and sample size
calculation for the Pearl Index.  Eur J Contracept Reprod Health
Care 2003, 8(2):87-92.
3. The European Agency for the Evaluation of Medicinal Products, Com-
mittee for Proprietary Medicinal Products (CPMP): Note for Guidance
on Clinical Evaluation of Steroid Contraceptives in Women . London 17
February 2000 CPMP/EWP/519/98. Section 4.3.
4. The European Agency for the Evaluation of Medicinal Products, Com-
mittee for Proprietary Medicinal Products (CPMP): Points to Consider
on Hormone Replacement Therapy . London 17 November 1997 CPMP/
EWP/021/97. Section 2.2.2.
5. World Medical Association: Declaration of Helsinki: ethical
principles for medical research involving human subjects.
JAMA 2000, 284(23):3043-5.
6. The European Agency for the Evaluation of Medicinal Products, Com-
mittee for Proprietary Medicinal Products (CPMP): Note for Guidance
on Good Clinical Practice . London 1 May 1996 CPMP/ICH/135/958.
7. World Health Organization Special Programme of Research, Devel-
opment and Research Training in Human Reproduction: The analy-
sis of vaginal bleeding patterns induced by fertility regulating
methods.  Contraception 1986, 34:253-260.
8. SAS Institute Inc: SAS/STAT® User's Guide, Version 9.1 Cary, NC: SAS
Institute Inc; 2004. 
9. Winston PH: Artificial Intelligence 2nd edition. Reading, Mass. Addison-
Wesley; 1984. 
10. Florek K, Lukaszewiez L, Perkal L, Steinhaus H, Zortchi S: Sur la lia-
son et la division des points d'un ensemble fini.  Colloquium
Mathematicum 1951, 2:282-285.
11. Sneath PHA: The application of computers to taxonomy.  Jour-
nal of General Microbiology 1957, 17:201-226.
12. Sørensen T: A method of establishing groups of equal ampli-
tude in plant sociology based on similarity of species content
and ist applications to analyses of the vegetation on Danish
commons.  Biologiske Skrifter 1948, 5:1-34.
13. Sokal RR, Michener CD: A statistical method for evaluating sys-
tematic relationships.  University of Kansas Science Bulletin 1958,
38:1409-38.
14. Ward JH: Hierachical grouping to optimize an objective func-
tion.  Journal of the American statistical Association 1963, 58:236-44.
15. Sarle WS: Cubic Clustering Criterion, SAS Technical Report A-108 Cary,
C: SAS Institute Inc; 1983. 
16. World Health Organization Special Programme of Research, Devel-
opment and Research Training in Human Reproduction: The analy-
sis of vaginal bleeding patterns induced by fertility regulating
methods.  Contraception 1986, 34:253-260.
17. Archer DF, Pickar JH: The assessment of bleeding patterns in
postmenopausal women during continuous combined hor-
mone replacement therapy: a review of methodology and
recommendations for reporting of the data.  Climacteric 2002,
5:45-59.
18. Mishell DR Jr, Guillebaud J, Westhoff C, Nelson AL, Kaunitz AM,
Trussell J, Davis AJ: Recommendations for standardization of
data collection and analysis of bleeding in combined hor-
mone contraceptive trials.  Contraception 2007, 75:11-5.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6874/9/21/prepub